New malaria vaccine effective in clinical trial
Wednesday, February 15, 2017 - 13:52
in Health & Medicine
Researchers have demonstrated in a clinical trial that a new vaccine for malaria called Sanaria® PfSPZ-CVac has been up to 100 percent effective when assessed at 10 weeks after last dose of vaccine. For the trial, scientists used malaria parasites provided by Sanaria.